HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF): CLINICAL CHALLENGES AND FUTURE THERAPIES

Authors

  • Situ Jingcheng

Keywords:

HFpEF, diastolic dysfunction, biomarkers, clinical management

Abstract

Heart failure with preserved ejection fraction (HFpEF) accounts for nearly 50% of heart failure cases. This study reviews pathophysiology, diagnostic difficulties, and treatment prospects.

Downloads

Download data is not yet available.

References

Borlaug BA. HFpEF: Pathophysiology and therapy. Circulation. 2021.

Solomon SD, et al. DAPA-HF trial. NEJM, 2020.

Downloads

Published

2025-10-04

How to Cite

Situ Jingcheng. (2025). HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF): CLINICAL CHALLENGES AND FUTURE THERAPIES. Journal of Applied Science and Social Science, 15(10), 33. Retrieved from https://www.internationaljournal.co.in/index.php/jasass/article/view/1954

Issue

Vol. 15 No. 10 (2025): Volume 15 Issue 10

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in the Journal of Applied Science and Social Science (JASSS) is protected by copyright. Authors retain the copyright to their work, and grant JASSS the right to publish the work under a Creative Commons Attribution License (CC BY). This license allows others to distribute, remix, adapt, and build upon the work, even commercially, as long as they credit the author(s) for the original creation.